David W. Johnson
Lecturer in Law
David Johnson has been teaching Negotiation at SLS annually since 2006, in conjunction with his full-time practice of law in Silicon Valley, from 1996 to date. He has testified before the California Senate on pending legislation addressing software liability. Thereafter he appeared before Congress, as lead counsel for the Business Software Alliance in hearings before the House Subcommittee for Science and Technology. In 2008, he returned to Washington to consult on the Waxman-Markey cap-and-trade energy bill, HR2454. He currently serves on the California State Bar Executive Committee on Alternative Dispute Resolution, and two of its subcommittees – Ethics, and Education. David is a regular speaker at conferences, seminars and panels on various subjects in law, science and technology, as well as negotiation.
David brings to his teaching a unique blend of breadth and depth in the practice of law. He began his career in the courtroom, with over 20 civil trials, jury and bench, state and federal. He has briefed and argued a dozen state appellate matters, with 6 opinions issued, including one state Supreme Court argument challenging the prima facie constitutionality of a sales tax on commercial speech. He has litigated scores of patent, copyright, trade secret, trade dress, antitrust, and business cases, and worked in IP and corporate governance in Silicon Valley with Fenwick & West and Morgan/Lewis, representing an array of technology clients including Apple, Brøderbund, Cisco, Compuware, Electronic Arts, GoRemote, Intuit, McKesson, Merrill-Lynch, Realtor.com, Sankyo Pharma, and The Computer History Museum, pro bono.
His first role as General Counsel was with a pioneer in the social media and online advertising space, AllAdvantage, Inc. Thereafter, as GC and COO of a Palo Alto-based innovation accelerator, MG Taylor, Inc., he negotiated and closed its joint-venture with Vanderbilt University Medical Center to create the nation’s first Healthcare Innovation Center, located at Vanderbilt’s Center for Better Health. David moved next into biotech as the Deputy General Counsel for Xenogen, Inc. (NYSE: XGEN), which coupled innovations in genetic engineering and in vivo optical-imaging invented and patented by Dr. Chris Contag, Stanford Professor of Microbiology & Immunology, resulting in breakthrough technologies advancing cancer research worldwide. David co-managed Xenogen’s public-public merger with Caliper Life Sciences (NYSE: CALP), a global microfluidics and drug discovery instrumentation developer; upon closing, he became Caliper’s Deputy General Counsel for two years. Thereafter, David became a Principal and General Counsel of Triage Consulting Group, a hospital revenue-cycle consultancy supporting the business offices of academic, children’s and other hospitals nationwide.
For his JSM degree in Law, Science & Technology, David’s interdisciplinary research and writing proposed that both object-modeling technique (OMT) and fuzzy set theories, as proven design schemas in computing, should therefore find applications in law, policy, and decision-making; eliciting from his faculty advisor the observation that he was “one of the most widely-read people I know." In addition to reading, David is a competitive golfer and sailboat racer, and a diligent but decidedly average skier.